Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Valeant's Investor Day Leaves Wall Street Recommending A "Buy" On Shares

18 Jun 2010

• By The Pink Sheet Daily

Valeant expects double digit growth in 2010.

Related Content

Valeant Pharmaceuticals To Buy Aton For $318 Mil.; Bolsters U.S. Specialty Business

03 May 2010

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.